ALDH1A3 has been shown to initiate breast cancer cell metastasis in the brain; therefore, targeting ALDH1A3 therapeutically was suggested to improve breast cancer patient survival [85]. This evidence concerns the gene ALDH1A3 and breast carcinoma.